ST Pharm Co.Ltd Cash Flow-to-Debt Ratio
ST Pharm Co.Ltd cash flow-to-debt ratio. ST Pharm Co.Ltd (237690) has a Cash Flow-to-Debt Ratio of -0.11x as of December 2025, meaning its operating cash flow of ₩-21.16 Billion could theoretically repay 0% of its total liabilities (₩189.56 Billion) in one year. Check ST Pharm Co.Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of ST Pharm Co.Ltd (2015–2025)
Cash flow-to-debt ratio of ST Pharm Co.Ltd from 2015 to 2025. Historical debt coverage capacity for ST Pharm Co.Ltd across 11 annual periods. Check ST Pharm Co.Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
ST Pharm Co.Ltd Cash Flow-to-Debt Ratio by Year (2015–2025)
ST Pharm Co.Ltd cash flow-to-debt ratio by year from 2015 to 2025. Year-by-year debt coverage analysis for ST Pharm Co.Ltd. For the full cash flow conversion analysis, see 237690 operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.07x | ₩13.99 Billion | ₩189.56 Billion | ▼ -85.2% |
| 2024 | 0.50x | ₩109.45 Billion | ₩218.88 Billion | ▲ +11012.0% |
| 2023 | 0.00x | ₩1.30 Billion | ₩288.53 Billion | ▼ -85.1% |
| 2022 | 0.03x | ₩7.03 Billion | ₩233.02 Billion | ▼ -27.1% |
| 2021 | 0.04x | ₩7.27 Billion | ₩175.59 Billion | ▲ +129.7% |
| 2020 | -0.14x | ₩-20.93 Billion | ₩150.24 Billion | ▲ +81.7% |
| 2019 | -0.76x | ₩-30.52 Billion | ₩40.12 Billion | ▼ -198.4% |
| 2018 | 0.77x | ₩10.77 Billion | ₩13.94 Billion | ▼ -56.8% |
| 2017 | 1.79x | ₩54.44 Billion | ₩30.42 Billion | ▲ +92.2% |
| 2016 | 0.93x | ₩50.78 Billion | ₩54.53 Billion | ▲ +173.0% |
| 2015 | 0.34x | ₩35.82 Billion | ₩105.04 Billion | — |